Please use this identifier to cite or link to this item: http://hdl.handle.net/20.500.12188/34427
DC FieldValueLanguage
dc.contributor.authorMihajlov, Kirilen_US
dc.contributor.authorTrajkovska Dokikj, Elenaen_US
dc.contributor.authorLabachevska Gjatovska, Liljanaen_US
dc.contributor.authorKostovski, Markoen_US
dc.contributor.authorJovchevski, Radomiren_US
dc.contributor.authorKovacheva Trpkovska, Danicaen_US
dc.contributor.authorIgnjatovikj Mihajlova, Ivanaen_US
dc.date.accessioned2025-12-05T07:30:02Z-
dc.date.available2025-12-05T07:30:02Z-
dc.date.issued2024-04-22-
dc.identifier.urihttp://hdl.handle.net/20.500.12188/34427-
dc.description.abstractIntroduction: The major risk factor for acquiring an infection with Clostridioides difficile (CDI) is a long-term antibiotic treatment. Contrarily, the treatment of severe CDI cases involves application of antibiotics like vancomycin or metronidazole. Our aim was to investigate the percentage of resistance to eight antibiotics (vancomycin, metronidazole, tetracycline, clindamycin, erythromycin, imipenem, ciprofloxacin and moxifloxacin) among Clostridioides difficile isolates, indirectly evaluating the risks of acquiring CDI and the risks of therapeutic failure.en_US
dc.language.isoenen_US
dc.publisherFaculty of Medicine, Ss. Cyril and Methodius University in Skopjeen_US
dc.relation.ispartofAcademic Medical Journalen_US
dc.subjectClostridioides difficile infectionen_US
dc.subjectC. difficileen_US
dc.subjectantimicrobial susceptibilityen_US
dc.titleANTIBIOTICS: CURE AND RISK FACTOR FOR CLOSTRIDIOIDESDIFFICILE INFECTIONen_US
dc.typeArticleen_US
dc.identifier.doi10.53582/AMJ2441041m-
item.grantfulltextnone-
item.fulltextNo Fulltext-
crisitem.author.deptFaculty of Medicine-
crisitem.author.deptFaculty of Medicine-
crisitem.author.deptFaculty of Medicine-
crisitem.author.deptFaculty of Medicine-
crisitem.author.deptFaculty of Medicine-
Appears in Collections:Faculty of Medicine: Journal Articles
Show simple item record

Google ScholarTM

Check

Altmetric


Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.